1764005016 unnamed file.jpg

Reliance bull run: RIL adds Rs 4.4 lakh crore in 2025 as telecom and O2C fire together; Should you buy or sell? Here’s what experts say

After a lacklustre 2024, Reliance Industries is staging one of its sharpest rebounds since the Covid year of 2020, with a broad set of triggers across energy, telecom and retail fueling a powerful rerating. The Nifty heavyweight has jumped more than 26% in 2025, adding Rs 4.4 lakh crore to its valuation and pushing its…

Read More
125545334.cms .png

Market slide hits Dalal Street’s richest: Big investors see portfolio erosion; few outliers buck the trend–check detail

Indian investors saw their portfolios shrink in the July-September quarter. A market downturn impacted most major investors, leading to substantial mark-to-market losses. Nemish Shah emerged as a notable gainer, increasing his portfolio value significantly. Other investors like Vijay Kedia and Madhusudan Kela reported modest gains. The late Rakesh Jhunjhunwala’s family holdings also saw a decline….

Read More
1764001963 unnamed file.jpg

‘Heightened exuberance’: RBI bulletin warns about overheated global markets; says fiscal–monetary push to lift investment in India

Fiscal, monetary and regulatory measures are expected to pave the way for a “virtuous cycle” of higher private investment-led growth, even as global trade uncertainties and external sector headwinds persist, the Reserve Bank of India (RBI) said in its November Bulletin released on Monday.An article on State of the Economy in the Bulletin noted that…

Read More
1763997682 unnamed file.jpg

US markets today: Nasdaq jumps nearly 2% as Alphabet leads AI rally; rate-cut hopes steady Wall Street

The US stock market moved higher on Monday as tech giants powered early gains and investors bet on another Federal Reserve rate cut in December, even as volatility continued to test sentiment.Alphabet was the day’s standout performer, soaring 5.2 per cent after fresh praise for its newest Gemini AI model. Its rally helped lift the…

Read More
1763996250 unnamed file.jpg

Capex momentum: Adani Group adds Rs 67,870 crore in new assets during H1; leverage stays below guidance despite expansion

Adani Group reported its strongest first-half performance in years, powered by record capital expenditure and higher operating earnings across its core infrastructure portfolio. The conglomerate added Rs 67,870 crore of gross assets in the first six months of FY26, taking its total asset base to Rs 6.77 lakh crore, and said it remains on track…

Read More
Buffett nurtures future growth.jpg

Warren’s wisdom! Learn how to build a long-term career the Warren Buffett way — essential tips you should know

Warren Buffett may be best known for shaping Berkshire Hathaway into a $1 trillion giant, but his greatest lessons extend far beyond investing. Earlier this month, the 95-year-old signalled his retirement and wrote his final shareholder letter, marking the end of six decades of steady, disciplined growth. Writing for ET Wealth, Devashish Chakravarty described Buffett’s…

Read More
1763993299 unnamed file.jpg

Credit pulse: NBFCs eye steady AUM rise as firms adopt risk-calibrated lending; unsecured and MSME segments face strain

A steady expansion in retail credit demand is expected to keep non-bank finance companies on an 18 per cent growth path, even as lenders turn more selective amid rising borrower leverage, Crisil Ratings has said. The agency noted that NBFCs are moderating their stance in pockets such as unsecured MSME loans, where repayment stress is…

Read More
1763991871 unnamed file.jpg

Biosimilar push: Dr Reddy’s gets EU nod for denosumab copy; Prolia, Xgeva rivals set for rollout

Dr Reddy’s Laboratories has secured a major regulatory milestone with the European Commission granting marketing authorisation for AVT03, its biosimilar to denosumab used in osteoporosis treatment. The approval covers all EU member states as well as Iceland, Liechtenstein and Norway under the European Economic Area framework.The company said AVT03 is a biosimilar version of Prolia…

Read More
1763980218 unnamed file.jpg

Trade revival push: India and Israel restart FTA talks after decade-long pause; GTRI says gains lie beyond goods trade

India’s stalled effort to negotiate a Free Trade Agreement with Israel has returned to focus after both governments finalised fresh Terms of Reference to restart talks, marking the first concrete movement since discussions drifted in 2014. The trade and economic policy think tank, Global Trade Research Initiative (GTRI) said the renewed push reflects a strategic…

Read More